InvestSMART

HeraMED Limited (ASX:HMD)

ALERT: Price-sensitive ASX Announcement for HMD
Current share price for HMD : $0.038 0.002 (5.56%)+
Announcement
Release
31 Jul 2026 12:42PM
Price at Release
$0.036
Full Release
download
Summary
HeraMED Limited, a company focused on digital transformation in maternity care, reported its Quarterly Activities and Cashflow for the June 2026 quarter. The company advanced its US commercialization strategy with significant progress in its partnership with Lee Health and Philips. The completion of Phase 1 at Lee Health demonstrated high virtual adoption and potential reductions in prenatal visits. HeraMED is also working on expanding its agreement with Philips for broader deployment in the US. The company reported a disciplined cash management approach, with a cash balance of A$2.93 million and a reduced operating cash outflow of A$638K for the quarter, providing an estimated 4.6 quarters of funding.
Key Points
  • HeraMED advanced its US commercialisation strategy.
  • Completion of Phase 1 at Lee Health with high virtual adoption.
  • Progress in expanding Philips commercial agreement.
  • Reported a cash balance of A$2.93 million.
  • Operating cash outflow reduced to A$638K.
  • Estimated 4.6 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.